World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
84
Citations
24716
World Ranking
931
National Ranking
58

Medicine

D-Index
90
Citations
29601
World Ranking
12210
National Ranking
662

Roland Buhl publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roland Buhl sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 503 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Roland Buhl D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roland Buhl sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 84 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Roland Buhl is affiliated with Johannes Gutenberg University of Mainz in Germany. Their research is primarily concentrated in the field of medicine, with a strong focus on pulmonary and respiratory medicine. Other subfields include physiology, immunology and allergy, emergency medical services, and surgery.

The main topics covered in Roland Buhl's work include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Allergic Rhinitis and Sensitization
  • Respiratory Support and Mechanisms
  • Pediatric health and respiratory diseases

Among the recent publications associated with Roland Buhl are:

  • Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes, 2021, European Respiratory Journal
  • Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update, 2023, npj Primary Care Respiratory Medicine
  • European Respiratory Society guidelines for the diagnosis of asthma in adults, 2022, European Respiratory Journal
  • Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study, 2023, The Lancet Respiratory Medicine
  • Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes, 2021, The Journal of Allergy and Clinical Immunology In Practice

Frequent coauthors in Roland Buhl's research collaborations include:

  • Christian Taube
  • Stephanie Korn
  • Eckard Hamelmann
  • Katrin Milger
  • Claus Vogelmeier

Roland Buhl's publications have appeared notably in the following venues:

  • Pneumologie
  • The Journal of Allergy and Clinical Immunology In Practice
  • European Respiratory Journal
  • Allergy
  • Respiratory Medicine

Best Publications

  • Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

    Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker

  • High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

    Maurits Demedts;Juergen Behr;Roland Buhl;Ulrich Costabel

  • The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

    Unknown

  • Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?

    Patrick Micke;Andreas Faldum;Tsegay Metz;Kai-Michael Beeh

  • Systemic deficiency of glutathione in cystic fibrosis.

    J. H. Roum;R. Buhl;N. G. McElvaney;Z. Borok

  • The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

    J. Bousquet;P. Cabrera;N. Berkman;R. Buhl

  • Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

    Oliver Pfaar;Claus Bachert;Albrecht Bufe;Roland Buhl

  • Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)

    Roland Buhl;François Maltais;Roger Abrahams;Leif Bjermer

  • Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    D. Robinson;M. Humbert;R. Buhl;A. A. Cruz

  • GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents

    Helen K Reddel;J Mark FitzGerald;Eric D Bateman;Leonard B Bacharier

  • Overall asthma control: The relationship between current control and future risk

    Eric D. Bateman;Helen K. Reddel;Göran Eriksson;Göran Eriksson;Stefan Peterson

  • Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

    Ronald Dahl;Kian Fan Chung;Roland Buhl;Helgo Magnussen

  • Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations

    P. Kuna;M. J. Peters;A. I. Manjra;C. Jorup

  • Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

    Unknown

  • Neutrophil Chemotactic Activity of Sputum From Patients With COPD: Role of Interleukin 8 and Leukotriene B4

    Kai M. Beeh;Oliver Kornmann;Roland Buhl;Sarah V. Culpitt

  • Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.

    Norbert Krug;Jens M Hohlfeld;Anne-Marie Kirsten;Oliver Kornmann

  • Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.

    Timm Volmer;Timo Effenberger;Christoph Trautner;Roland Buhl

  • Safety and tolerability of omalizumab

    J. Corren;T. B. Casale;B. Lanier;R. Buhl

  • Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

    M. Schuler;R. Herrmann;J. L.P. De Greve;A. K. Stewart

  • Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.

    Sumita Khatri;Wendy Moore;Peter G. Gibson;Richard Leigh

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone.

    Olle Zetterström;R Buhl;H Mellem;M Perpina

Frequent Co-Authors

Claus Vogelmeier
Claus Vogelmeier Philipp University of Marburg
Christian Taube
Christian Taube Johannes Gutenberg University of Mainz
Jean Bousquet
Jean Bousquet University of Montpellier
Ludger Klimek
Ludger Klimek Ghent University
Claus Bachert
Claus Bachert Karolinska Institute
Marc Humbert
Marc Humbert University of Paris-Saclay
Eric D. Bateman
Eric D. Bateman University of Cape Town
Thomas Keil
Thomas Keil University of Würzburg
Thomas B. Casale
Thomas B. Casale University of South Florida
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities in health and science fields. Many professionals enhance their qualifications through accredited online mph programs easy to get into. These public health degrees complement microbiology knowledge, broadening expertise in disease prevention and health management.

Alternative career pathways include becoming a child life specialist, a role focused on supporting children’s emotional wellbeing in medical settings. This field integrates biological sciences with psychology and social support skills, appealing to those with a microbiology background who want direct patient interaction.

For those facing unique challenges, certain degrees offer accessible options. The degrees felons can get list highlights online programs that provide second chances while building a solid career foundation, including some related to health sciences.

Moreover, pursuing advanced roles such as a functional medicine nurse practitioner can be rewarding both professionally and financially. Insights into the functional medicine nurse salary showcase how interdisciplinary medical knowledge can translate into a lucrative healthcare career.

Best Scientists Citing Roland Buhl

Trending Scientists

Recently Published Articles